# Senseonics (SENS) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/SENS
## Company Profile
- Ticker: SENS
- Exchange: NYSE
- Sector: Biopharma
- Location: United States
- Tags: MedTech, Cardio-Metabolic
## Stock Data
- Close: 7.87 USD
- Market cap: 358634369.55 USD
- Last updated: 2026-08-11
## Business Overview
### Implantable Glucose Monitoring
Senseonics develops long-term implantable continuous glucose-monitoring systems for people with diabetes. Its technology places a fluorescence-based sensor under the skin rather than relying on frequently replaced transcutaneous sensors.
### Eversense 365
Eversense 365 is designed to provide up to one year of continuous glucose data from a single implanted sensor. A removable external transmitter powers the sensor and sends readings and alerts to a mobile application. Senseonics manufactures the system and now directly manages U.S. commercialization. The company is also transitioning more international sales and marketing activities in-house.
## Why The Stock Is Moving

As of Aug 11, 2026, SENS closed up 4.38% at $7.87. No new same-company headline was identified in the current news window.

## Recent News
- 2026-08-06 20:01 EST — [Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/SENS/senseonics-holdings-inc-reports-second-quarter-2026-financial-results-1a8e70d3) — Source: Senseonics
- 2026-06-10 12:00 EST — [Senseonics and Welldoc Partner to Develop Next-Generation App for Eversense® 365](https://biopharmsignal.com/news/SENS/senseonics-and-welldoc-partner-to-develop-next-generation-app-for-eversense-365-6acf0328) — Source: Senseonics
- 2026-06-06 21:00 EST — [Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems](https://biopharmsignal.com/news/SENS/real-world-evidence-of-eversense-365-presented-at-ada-demonstrating-strong-perfo-37d528e7) — Source: Senseonics
- 2026-06-01 12:00 EST — [Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026](https://biopharmsignal.com/news/SENS/senseonics-highlights-analyst-event-and-oral-presentation-of-eversense-365-real--5826a5ba) — Source: Senseonics
- 2026-05-07 20:01 EST — [Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/SENS/senseonics-holdings-inc-reports-first-quarter-2026-financial-results-a7b4bee3) — Source: Senseonics